After-Hours Movers Oct 5, 2026: OLOX, JAGX, QTEX

OLOX — Olenox Industries Inc. (+81.0%)

Olenox Industries jumped 81.0% after the bell on October 5, trading up to $1.62 on 53.1 million after-hours shares — a staggering figure given the stock's 20-day average of just 2.1 million shares. That volume surge alone is the loudest signal here: something captured heavy speculative attention in the post-close session.

Why it moved: No authoritative catalyst line is available for OLOX. The only recent SEC activity is a routine 8-K/A amendment filed October 2 (exhibits, flagged neutral). No earnings release, deal announcement, or explanatory headline accompanied tonight's spike. With no clear fundamental catalyst, this looks like a momentum- and sentiment-driven move, the kind that can appear in ultra-micro-cap names when speculative interest suddenly floods in.

The technical and fundamental picture underscores the risk. Olenox carries a market cap of just $1.5 million — one of the smallest names in the US universe — and sits 94.5% below its 52-week high. StockSetups rates it Grade D with a conviction score of 0/100 and a squeeze score of just 1/100; short interest is negligible at 52,365 shares, so a squeeze dynamic is not the likely driver. RSI of 33 going into the close suggests the regular session left the stock in oversold territory, which can attract speculative bids after hours.

Moves of this magnitude on a $1.5M market-cap name with no disclosed catalyst are among the most dangerous to chase. After-hours liquidity (the ease of buying or selling without moving the price significantly) is a fraction of regular-session liquidity, meaning prices can move sharply on small order flow and reverse just as fast at the next open.

JAGX — Jaguar Health, Inc. (+34.5%)

Jaguar Health traded up 34.5% after the bell to $6.34 on 4.3 million after-hours shares, roughly in line with its 20-day average of 4.7 million — meaning tonight's reaction drew real participation, not just a thin-market blip.

Why it moved: The catalyst here is well-documented. According to headlines from Yahoo Finance, TradingView, and AD HOC NEWS (October 3–4, 2026), Jaguar Health declared a special stock dividend tied to a five-for-one conversion of its Series R Preferred shares. Special dividends and preferred-share conversion announcements can shift the implied value of common shares and often draw a sharp market reaction, particularly in smaller healthcare names where the capital structure is closely watched.

It's worth noting that JAGX's recent SEC filing history is heavily bearish in tone: a follow-on offering (424B5), two dilutive 8-K filings, and an agreement-termination 8-K all filed within the past two weeks. That context matters — the special dividend announcement is the immediate post-close catalyst, but the broader backdrop includes repeated dilution events. The largest disclosed stake stands at 10.0% of the float.

On the StockSetups technical scorecard, JAGX carries a conviction score of 24/100, a squeeze score of 38/100, and a Grade D rating. ADX of 52 signals a strongly trending tape, though the moving-average stack is bearish and the RS rating sits at 1 — meaning JAGX has badly underperformed the broad market over the trailing period. The stock is also 99.4% below its 52-week high, a reminder of how far it has fallen. After-hours moves on corporate-action announcements like this can extend or fully reverse by the open, particularly when the underlying equity has a history of dilution.

QTEX — QTREX Quantum Ltd. (+26.1%)

QTREX Quantum traded up 26.1% after the bell to $1.98 on 14.2 million after-hours shares, above its 20-day average of 11.9 million. The above-average volume gives the move more credibility than a purely thin-market print.

Why it moved: The primary catalyst appears to be a breakthrough cryogenic interconnect test and progress toward finalizing a major quantum computing agreement, as reported by The Globe and Mail on October 2. Benzinga also flagged the stock climbing that same day. Technology milestones in the quantum computing space — especially when paired with the word "agreement" — can drive outsized speculative moves in small-cap names. A neutral 6-K (foreign-event filing) was submitted to the SEC on October 1, consistent with a non-US-domiciled company disclosing developments abroad.

The StockSetups data adds an interesting layer: QTEX has a squeeze score of 51/100 (the midpoint on a 0–100 scale), meaning roughly half the conditions for a short squeeze — where traders who bet against the stock are forced to buy shares to cover their positions, amplifying a rally — are in place. Short interest stands at 3.84 million shares with 0.9 days to cover (how many average trading days it would take short sellers to fully buy back their positions). That's not extreme, but it's enough to add fuel to a momentum move. RSI of 79 going into the close signals the stock was already overbought on a standard 0–100 momentum scale, which raises the odds of a pullback.

The CEO, Ben-Noon Dagi Shahar, bought 168,894 shares (~$120K) on September 28 — a Form 4 insider buy that StockSetups captures in its smart-money score of 36/100. Insider buying near the price action is generally seen as a constructive signal, though it preceded tonight's after-hours move by about a week. QTEX sits 49.0% below its 52-week high with a Grade D rating, so the stock remains in a longer-term downtrend even as tonight's catalyst sparked a sharp post-close pop.

APUS — Apimeds Pharmaceuticals US, Inc. (+20.5%)

Apimeds Pharmaceuticals traded up 20.5% after the bell to $5.29 on 385,862 after-hours shares — well below its 20-day average of 7.5 million. That thin post-close volume means the percentage move should be treated with extra skepticism; after-hours prices on light volume are especially prone to reversal.

Why it moved: Multiple sources from October 5 itself — Benzinga, timothysykes.com, and stockstotrade.com — describe APUS whipsawing throughout the regular session on extreme volatility, drawing day traders targeting price swings rather than a single clean catalyst. Benzinga asked "Why Is Apimeds Pharmaceuticals Stock Gaining Monday?" as of today's date, and the trader-focused outlets characterize the action as volatility-chasing around a stock that had already made a large recent run. An October 1 Form 8-K related to management was filed but flagged neutral.

Apimeds is a micro-cap pharmaceutical name with a market cap of just $6.6 million, a free float of only 54.4% (meaning less than half the shares are freely tradeable — a "low-float" stock where relatively small order flow can move the price dramatically), and it sits 87.5% below its 52-week high. StockSetups rates it Grade D, conviction 38/100, squeeze score 29/100. Short volume was elevated at 59% of the day's volume, a sign that short sellers were active during the session. APUS has appeared in our movers coverage before — see the Top Stock Movers Sept 24, 2026 and Premarket Movers Sept 24, 2026 recaps for context on its prior volatility episodes.

The after-hours pop on only ~386K shares, following an already whipsaw regular session, is the kind of setup that most frequently leads to an open-of-day fade. Manage risk accordingly.

The bottom line

Tonight's four after-hours movers share a common thread: they are small- to micro-cap names with high volatility, and all four are Grade D stocks sitting deep below their 52-week highs. After-hours trading happens on thin liquidity — a fraction of the volume seen during regular hours — which means percentage moves can look dramatic but are often driven by a small number of orders. These prices can extend sharply higher or reverse completely at the next regular-session open.

Chasing stocks after they have already posted 20%–81% after-hours gains is high-risk behavior. Earnings reactions, corporate-action announcements, and technology-milestone catalysts all have the potential to be reinterpreted by the broader market once full liquidity returns in the morning. Patterns break, squeezes fail, and thinly traded micro-caps are among the most dangerous names to hold overnight without a clear risk-management plan. Do your own research before making any trading decisions — nothing here is financial advice or a recommendation to buy or sell any security.

StockSetups scans the full ~12,300-stock US universe after every close and every premarket morning, flagging the biggest after-hours movers alongside pattern detections, conviction scores, squeeze scores, and smart-money signals. Check tonight's full scan for the complete picture. You can also see what moved during today's regular session in the Top Stock Movers Oct 5, 2026 recap, or look back at After-Hours Movers Oct 2, 2026 for recent after-hours context.